COVID-19 in Cirrhotic Patients: Is Portal Vein Thrombosis a Potential Complication?

por Hassnine, Alshymaa A, Elsayed, Amr M
Publicado 2022

Impact of COVID-19 on endoscopic follow-up of gastroesophageal varices

por Elsayed, Amr M., Fouad, Yasser M., Hassan, Hatem A., Hassanin, Taha M., Abbas, Abbas M., Hassnine, Alshymaa A.
Publicado 2022

Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt

por Hassnine, Alshymaa A., Saber, Mona A., Fouad, Yasser M, Sarhan, Hatem, Elsayed, Mahmoud MA, Zaki, Zaki M, Abdelraheem, Ehab M, Abdelhalim, Safaa M, Elsayed, Amr M.
Publicado 2022

NAFLD mark: an accurate model based on microRNA-34 for diagnosis of non-alcoholic fatty liver disease patients

por Mohamed, Amal A., El-Demery, Ahmed, Al-Hussain, Eman, Mousa, Shroouk, Halim, Ahmed Abdel, Mostafa, Sahar M., Abdelghany, Reda S., Mahmoud, Seham M., Elkady, Mohammad A., Raafat, Khaled, Hassnine, Alshymaa A., Omran, Mohamed M.
Publicado 2021

Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 an...

por Abu El-Makarem, Mona A., Kamel, Mariana F., Mohamed, Ahmed A., Ali, Hisham A., Mohamed, Mahmoud R., Mohamed, Alaa El-Deen M., El-Said, Ahmed M., Ameen, Mahmoud G., Hassnine, Alshymaa A., Hassan, Hatem A.
Publicado 2022

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease

por Mohamed, Amal A, Abo-Elmatty, Dina M, Ezzat, Omnia, Mesbah, Noha M, Ali, Nada S, Abd El Fatah, Aliaa Sayed, Alsayed, Eman, Hamada, Mahmoud, Hassnine, Alshymaa A, Abd-Elsalam, Sherief, Abdelghani, Ahmed, Hassan, Mohamed Badr, Fattah, Shaimaa A
Publicado 2022